Blood Glucose Testing Market to Shows Widespread Expansion by 2025

Seattle, WA -- (SBWire) -- 12/10/2019 --Blood glucose testing is used to measure the amount of glucose in the blood. The process is primarily used in treatment and management of type 1 diabetes, type 2 diabetes, and gestational diabetes. It is also used to test for hypoglycemia—a condition that is characterized by very low levels of glucose in the blood.

Increasing prevalence of diabetes is expected to boost growth of Asia Pacific blood glucose testing market over the forecast period. For instance, according to International Diabetes Federation, 425 million people have diabetes in the world and 159 million of which belong to the western Pacific region. Moreover, the number of people suffering from diabetes is expected to reach 183 million in western Pacific region by 2045. Moreover, a recent review: Prevalence of Gestational Diabetes Mellitus in Eastern and Southeastern Asia: A Systematic Review and Meta-Analysis, published in 2018, reported that the prevalence of gestational diabetes mellitus in Eastern and Southeast Asia is 10.1%.

Download Sample Copy with In-depth Analysis @ https://www.stratagemmarketinsights.com/sample/7514

Increasing prevalence of hypoglycemia is expected to propel growth of Asia Pacific blood glucose testing market. For instance, according to Asia Pacific Real-Life Effectiveness and Care Patterns of Diabetes Management (Asia Pacific RECAP-DM) Study, the prevalence of hypoglycemia was reported at 36%. Moreover, increasing R&D related to blood glucose testing is also expected to fuel growth of the market. For instance, in March 2019, National Chung Hsing University, in collaboration with Tyson Bioresearch Inc., reported use of hydrophilic and positively charged ?-poly-l-lysine (?PLL) as the entrapment matrix for the immobilization of negatively charged glucose oxidase (GOx) and ferricyanide (FIC) on screen-printed carbon electrodes to construct a disposable second-generation glucose biosensor.

Key players in the market are focused on adopting partnership and collaboration strategies to expand their product portfolio. For instance, in April 2019, WaveForm Technologies Inc. and A. Menarini Diagnostics S.r.l. announced a partnership to commercialize the WaveForm Technologies Continuous Glucose Monitor (CGM). In October 2018, AgaMatrix partnered with Arcadia Group, under which AgaMatrix's proprietary blood glucose monitoring (BGM) technology was used for the Choice line of diabetes products marketed by Arcadia.

Key Takeaways:

- Increasing prevalence of diabetes is expected augment growth of Asia Pacific blood glucose testing market over the forecast period
- Key players in the market are focused on adopting inorganic growth strategies to expand their product portfolio
- Major players operating in Asia Pacific blood glucose testing market include, Menarini Diagnostics, Abaxis, Abbott, Acon, AgaMatrix, Bayer, and Bio-Rad

In this report, the Asia-Pacific Blood Glucose Testing market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Blood Glucose Testing for these regions, from 2014 to 2025 (forecast), including
- China
- Japan
- South Korea
- Taiwan
- India
- Southeast Asia
- Australia

Inquiry for Customize Report With Discount @ https://www.stratagemmarketinsights.com/quiry/7514

Asia-Pacific Blood Glucose Testing market competition by top manufacturers/players, with Blood Glucose Testing sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
- American Diabetes Association
- Diabetes
- Menarini Diagnostics
- Abaxis
- Abbott
- Acon
- AgaMatrix
- Bayer
- Bio-Rad

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
- Desktop Device
- Portable Device
- Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Blood Glucose Testing for each application, includin
- Hyperglycemia (High Blood Glucose)
- Tight Diabetes Control
- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Purchase this premium research report @ https://www.stratagemmarketinsights.com/cart/7514

About Stratagem Market Insights
Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with an cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our reports cover various end-use industries such as Aerospace and Defense, Agriculture, Food and Beverages, Automotive, Chemicals and Materials, Consumer Goods and Retail, Electronics, Energy, Mining, and Utilities, Pharmaceuticals, Manufacturing and Construction, Services, and Healthcare, and ICT.